These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21199922

  • 1. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
    Cirillo I, Vaccaro N, Balis D, Redman R, Matzke GR.
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
    Guenter SG, Iven H, Boos C, Bruch HP, Muhl E.
    Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
    [Abstract] [Full Text] [Related]

  • 3. Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
    Roberts JA, Udy AA, Bulitta JB, Stuart J, Jarrett P, Starr T, Lassig-Smith M, Roberts NA, Dunlop R, Hayashi Y, Wallis SC, Lipman J.
    J Antimicrob Chemother; 2014 Sep; 69(9):2508-16. PubMed ID: 24879665
    [Abstract] [Full Text] [Related]

  • 4. Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M, Tiula E, Takkunen O, Backman JT, Neuvonen PJ.
    J Antimicrob Chemother; 2001 Dec; 48(6):881-5. PubMed ID: 11733473
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS, Fish DN, Abraham E, Teitelbaum I.
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
    Fish DN, Teitelbaum I, Abraham E.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
    [Abstract] [Full Text] [Related]

  • 7. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M, Tiula E, Backman JT, Neuvonen PJ.
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C, Cotta MO, Muller L, Wallis SC, Lipman J, Lefrant JY, Roberts JA.
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [Abstract] [Full Text] [Related]

  • 10. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Roger C, Wallis SC, Muller L, Saissi G, Lipman J, Lefrant JY, Roberts JA.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
    [Abstract] [Full Text] [Related]

  • 11. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D, Ji D, Xie H, Xu B, Liu Y, Li L.
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 15. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY.
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [Abstract] [Full Text] [Related]

  • 16. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE.
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [Abstract] [Full Text] [Related]

  • 17. Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.
    Samtani MN, Vaccaro N, Cirillo I, Matzke GR, Redman R, Nandy P.
    ISRN Pharmacol; 2012 Apr; 2012():782656. PubMed ID: 22888451
    [Abstract] [Full Text] [Related]

  • 18. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N, Mbatchi LC, Maseda E, Luque S, Grau S, Wallis SC, Muller L, Lipman J, Roberts JA, Lefrant JY, Roger C.
    Ther Drug Monit; 2021 Dec 01; 43(6):747-755. PubMed ID: 33560097
    [Abstract] [Full Text] [Related]

  • 19. Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy.
    Chappell K, Kimmons LA, Haller JT, Canada RB, He H, Hudson JQ.
    J Crit Care; 2021 Feb 01; 61():216-220. PubMed ID: 33217623
    [Abstract] [Full Text] [Related]

  • 20. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
    Pea F, Viale P, Lugano M, Pavan F, Scudeller L, Della Rocca G, Furlanut M.
    Am J Kidney Dis; 2004 Dec 01; 44(6):1097-102. PubMed ID: 15558532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.